Literature DB >> 14898762

Controlled trials of the treatment of haemolytic disease of the newborn.

P L MOLLISON, W WALKER.   

Abstract

Entities:  

Keywords:  ERYTHEMA NODOSUM/therapy

Mesh:

Year:  1952        PMID: 14898762     DOI: 10.1016/s0140-6736(52)91949-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Exchange transfusion in haemolytic disease of the newborn.

Authors:  W WALKER; G A NELIGAN
Journal:  Br Med J       Date:  1955-03-19

2.  "Early" exchange transfusion.

Authors:  W WALKER
Journal:  Br Med J       Date:  1961-12-09

3.  Kernicterus in prematures.

Authors:  J W GERRARD
Journal:  Can Med Assoc J       Date:  1957-10-01       Impact factor: 8.262

4.  HAEMOLYTIC disease of the newborn.

Authors: 
Journal:  Can Med Assoc J       Date:  1957-10-01       Impact factor: 8.262

5.  Haemolytic disease of the newborn.

Authors:  E A WILLIAMS
Journal:  Br Med J       Date:  1956-01-21

6.  Haemolytic disease of newborn: delivery at term of living affected infant after previous stillbirths.

Authors:  K V COOPER; J R PINKERTON
Journal:  Br Med J       Date:  1957-05-25

7.  Kernikterus not associated with haemolytic disease.

Authors: 
Journal:  Arch Dis Child       Date:  1957-04       Impact factor: 3.791

8.  Influence of selective induction of labour on mortality in haemolytic disease of the newborn.

Authors:  O D FISHER
Journal:  Br Med J       Date:  1957-03-16

9.  A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy.

Authors:  Claudio Velati
Journal:  Blood Transfus       Date:  2007-01       Impact factor: 3.443

10.  Forty years of anti-D immunoprophylaxis.

Authors:  Giorgio Reali
Journal:  Blood Transfus       Date:  2007-01       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.